LITS Lite Strategy Inc.

Price (delayed)

$0.827

Market cap

$28.14M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2

Enterprise value

$20.59M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 1

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta ...

Highlights
The equity has soared by 191% YoY but it fell by 31% QoQ
The EPS has soared by 58% YoY but it has contracted by 16% from the previous quarter
LITS's net income has dropped by 92% year-on-year and by 53% since the previous quarter

Key stats

What are the main financial stats of LITS

LITS stock price

How has the Lite Strategy stock price performed over time
Intraday
-4.83%
1 week
-18.92%
1 month
-27.46%
1 year
-62.24%
YTD
-37.35%
QTD
-28.71%

Financial performance

How have Lite Strategy's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$58.09M
Net income
-$60.82M
Gross margin
N/A
Net margin
N/A
LITS's net income has dropped by 92% year-on-year and by 53% since the previous quarter
The operating income has plunged by 73% YoY and by 48% from the previous quarter

Price vs fundamentals

How does LITS's price correlate with its fundamentals

Growth

What is Lite Strategy's growth rate over time

Valuation

What is Lite Strategy stock price valuation
P/E
N/A
P/B
0.53
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 58% YoY but it has contracted by 16% from the previous quarter
The equity has soared by 191% YoY but it fell by 31% QoQ
The stock's price to book (P/B) is 67% less than its 5-year quarterly average of 1.7 and 30% less than its last 4 quarters average of 0.8

Efficiency

How efficient is Lite Strategy business performance
Lite Strategy's ROIC has soared by 62% YoY but it has decreased by 19% from the previous quarter
LITS's return on assets is down by 32% since the previous quarter but it is up by 19% year-on-year
The ROE fell by 32% QoQ but it rose by 29% YoY

Dividends

What is LITS's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Lite Strategy financials performed over time
The total assets has surged by 178% year-on-year but it has declined by 30% since the previous quarter
The company's quick ratio fell by 39% YoY but it rose by 25% QoQ
Lite Strategy's debt is 100% lower than its equity
The equity has soared by 191% YoY but it fell by 31% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.